It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Epidemiological study shows inconsistent results in the association between endometriosis and Systemic lupus erythematosus (SLE). We conducted a nationwide retrospective cohort study and analyzed data from the Taiwan Longitudinal Health Insurance Research Database 2000 (n = 958,349) over a 13-year follow-up period (2000–2013). After matching 1930 SLE women with 7720 non-SLE women in a 1:4 ratio by age, we used Cox proportional hazard regression to calculate the adjusted hazard ratio (aHR) for endometriosis diagnosed after SLE. We also used a diagnosis of endometriosis with previous gynecologic surgery codes as secondary outcomes and performed sensitivity analyses using a landmark analysis. After adjustment for age, urbanization, income, length of hospital stay, and comorbidities in the age-matched group, women with SLE had a higher risk of endometriosis than women without SLE (aHR 1.32, 95% CI 1.02–1.70). When we defined endometriosis as patients with an ICD-9 endometriosis code after undergoing gynecologic surgery, the increased risk of endometriosis in patients with SLE was not significant. Our findings suggest that the risk of endometriosis was significantly elevated in the cohort of women with SLE compared with the age-matched general cohort of women. The burden of endometriosis in SLE patients requires special attention.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Chimei Hospital, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Tainan City, Taiwan; Chung Shan Medical University, Institute of Medicine, College of Medicine, Taichung City, Taiwan (GRID:grid.411641.7) (ISNI:0000 0004 0532 2041)
2 Chung Shan Medical University, Institute of Medicine, College of Medicine, Taichung City, Taiwan (GRID:grid.411641.7) (ISNI:0000 0004 0532 2041); Chung Shan Medical University Hospital, Department of Allergy, Immunology and Rheumatology, Taichung City, Taiwan (GRID:grid.411645.3) (ISNI:0000 0004 0638 9256)
3 Chung Shan Medical University, Institute of Medicine, College of Medicine, Taichung City, Taiwan (GRID:grid.411641.7) (ISNI:0000 0004 0532 2041); Chung Shan Medical University Hospital, Department of Medical Research, Taichung City, Taiwan (GRID:grid.411645.3) (ISNI:0000 0004 0638 9256)
4 Chung Shan Medical University, Institute of Medicine, College of Medicine, Taichung City, Taiwan (GRID:grid.411641.7) (ISNI:0000 0004 0532 2041); Chung Shan Medical University Hospital, Department of Allergy, Immunology and Rheumatology, Taichung City, Taiwan (GRID:grid.411645.3) (ISNI:0000 0004 0638 9256); China Medical University, Graduate Institute of Integrated Medicine, Taichung City, Taiwan (GRID:grid.254145.3) (ISNI:0000 0001 0083 6092)